Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluating combination therapies for asthma: pros, cons, and comparative benefits.

Therapeutic advances in respiratory disease - 1 Jun 2008

Bjermer Leif

Abstract excerpt

Combination therapies with inhaled corticosteroids (ICS) and either long-acting beta2 agonists (LABA) or leukotriene receptor antagonists (LTRA) are commonly used to help patients maintain control of their asthma. LABA and LTRA have different mechanisms of action and both provide complementary be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Adrenergic beta-Agonists
Share to Asthma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Dose-Response Relationship, Drug

Share to Drug Therapy, Combination

Share to Phenotype

Source

Identifiers

PMID: 19124367
DOI: 10.1177/1753465808092280

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19124367-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluating combination therapies for asthma: pros, cons, and comparative benefits.PMID 19124367Read ↗

New and existing pharmacotherapeutic options for persistent asthma and COPD.Semantic proximity Read ↗

Molecular Mechanisms of Combination Therapy With Inhaled Corticosteroids and Long-Acting β-AgonistsSemantic proximity Read ↗

Biologic Therapy and Asthma.Semantic proximity Read ↗

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.Semantic proximity Read ↗

Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap.Semantic proximity Read ↗

Benefit-risk assessment of long-acting beta2-agonists in asthma.Semantic proximity Read ↗

Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.Semantic proximity Read ↗

Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.Semantic proximity Read ↗

Optimizing maintenance therapy in pediatric asthma.Semantic proximity Read ↗

Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.Semantic proximity Read ↗

Future treatment for asthma.Semantic proximity Read ↗

The emerging role of tiotropium for patients with asthma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.